K-numberK242798
Device nameAirmod
ApplicantHeroic Faith International , Ltd.
Product codeBZQ
Device classClass II
Decision dateFeb 28, 2025
DecisionSubstantially Equivalent
Regulation868.2375
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Airmod is an Android-based software application that monitors respiratory rate in sedated or anesthetized adult patients during procedural sedation. It uses acoustic signals from breathing sounds detected by an AccurSound Electronic Stethoscope AS-101 placed on the patient's neck, processes these signals through AI-based algorithms, and displays continuous respiratory rate measurements for use by credentialed healthcare professionals in hospitals and healthcare facilities.

Technological characteristics

Airmod uses acoustic signal processing from upper airway sounds to calculate respiratory rate, with sensors placed on the patient's neck, whereas the primary predicate uses pulse oximetry with finger-mounted sensors. Both devices are software-based systems providing continuous respiratory rate monitoring with similar accuracy ranges (Airmod: 4-35 ±2.7 breaths/min; predicate: 4-40 ±1 breath/min). Airmod operates as a mobile Android application, while the predicate is integrated software on a patient monitor.

Test standards cited

IEC 62304 for software testing; FDA guidance on Content of Premarket Submissions for Device Software Functions; FDA guidance on Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions; bench performance testing including active noise cancellation validation.

Substantial equivalence argument

The intended use is substantially similar: both continuously monitor respiratory rate non-invasively in adult patients in hospital settings. Although Airmod uses acoustic signals instead of pulse oximetry and places sensors on the neck rather than the finger, these technological differences do not present new safety or effectiveness issues because: (1) clinical testing demonstrated non-inferiority to capnography with RMSE of 2.689 BPM, meeting the primary outcome; (2) the reference predicate K120984 (Masimo Acoustic Monitoring) supports acoustic-based respiratory monitoring as an established technology; and (3) the performance characteristics are within the established ranges for respiratory rate monitors.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →